ZQFTN and Methotrexate Combination Therapy for Rheumatoid Arthritis
This paper critically reviews a systematic review and meta-analysis by Chen et al. (2015) examining the combined use of ZhengqingFengtongning (ZQFTN) and Methotrexate (MTX) in treating rheumatoid arthritis (RA). The review outlines the prevalence and burden of RA, evaluates the study's methodological strengths — including its use of randomized controlled trials and adherence to American Rheumatism Association diagnostic standards — and identifies key limitations such as the geographic restriction of included studies to China, small participant sample sizes, and variable journal quality. The paper ultimately calls for careful scrutiny before applying these findings in broader clinical contexts.
- Introduction to Rheumatoid Arthritis and Treatment Options: RA prevalence, burden, and standard treatments overview
- Strengths of the Study: Commendable design features and lack of bias
- Methodology and Study Design: RCT approach, participant selection, and diagnostic standards
- Limitations and Areas of Concern: Geographic restriction, small samples, and journal quality issues
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Clearly situates the reviewed study within the broader clinical context of rheumatoid arthritis prevalence and treatment burden before offering critique.
- Balances praise for methodological strengths with substantive concerns, demonstrating critical thinking rather than simple summary.
- Identifies specific, concrete limitations — geographic restriction, sample sizes, and journal quality — rather than relying on vague generalizations.
Key academic technique demonstrated
This paper demonstrates the critical appraisal technique commonly used in evidence-based medicine. Rather than simply restating the source article's findings, the writer evaluates the study's design choices, participant selection rationale, and the external validity of its conclusions. This approach shows how to engage analytically with a published meta-analysis by weighing methodological merit against practical limitations.
Structure breakdown
The paper follows a four-part structure: an introductory section establishing the clinical background and treatment landscape for RA; a section highlighting the study's commendable features; a section affirming and explaining the methodology; and a concluding critical section identifying geographic, sample size, and publication quality concerns. This mirrors the standard critical appraisal format expected in health sciences courses.
Introduction to Rheumatoid Arthritis and Treatment Options
Rheumatoid arthritis (RA) is a protracted, systemic inflammatory disease characterized by inflammation of the synovial soft tissue and damage to articular tendons and bone. These effects bring about extreme incapacity, functional deterioration, and increased mortality. RA is the most prevalent rheumatic disease, with an estimated prevalence of approximately one percent in North America and Europe, while Southeast Asia has a somewhat lower rate of around 0.3%. The disease is an area of major concern, as it is estimated that at present, approximately five million individuals suffer from rheumatoid arthritis. This has become both a social and economic problem, as the disease places a substantial burden on patients, their households, and society as a whole.
Treatment options for RA include anti-inflammatory drugs — specifically non-steroidal anti-inflammatory drugs (NSAIDs), which can be obtained from a variety of sources. There are also Disease-Modifying Anti-Rheumatic Drugs (DMARDs). Methotrexate (MTX) is one of the latter category of drugs and is considered a first-line treatment for rheumatoid arthritis. These treatment approaches are generally regarded as not having adverse impacts on disease progression such as retardation or impediment of radiographic outcomes.
Strengths of the Study
There are notable strengths of the study by Chen et al. (2015) that are commendable. First, the participant groups consist of those using ZQFTN (ZhengqingFengtongning) together with MTX, contrasted against participants who used MTX alone. This comparison is important because it enables a clear assessment of the efficacy and safety of the drug combination. Additionally, the study reported no conflicts of interest. Furthermore, any duplicate studies identified in the literature were excluded from the review.
Methodology and Study Design
The selection of methodology used in this study is well-suited to its research aims. The use of randomized controlled trials (RCTs) is appropriate for this type of investigation, as it is for many medical studies. The authors ensured that participants had taken ZQFTN in combination with MTX, and contrasted this group with participants who had taken MTX only.
The authors and researchers also took careful measures to verify that all participants were confirmed patients with a clear diagnosis of RA. The diagnostic principles and standards applied in the clinical trials were conducted in accordance with the criteria established by the American Rheumatism Association. Given this rigorous approach, the use of ZQFTN as the active treatment intervention was an appropriate and well-justified choice.
Create your account
Always verify citation format against your institution’s current style guide requirements.